Navigation Links
VNUS Medical's Patent Lawsuit Against Laser Competitors to Proceed to Trial
Date:10/3/2007

SAN JOSE, Calif., Oct. 3 /PRNewswire-FirstCall/ -- The patent lawsuit by VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS) against three endovenous laser competitors, Diomed, AngioDynamics and Vascular Solutions, is set to proceed to trial after the court's denial of summary judgment motions filed by both sides. In its motions VNUS had asked the court to decide before trial that the three defendants infringed the VNUS patents, while the defendants countered with their own motions seeking pre-trial rulings that the VNUS patents were invalid. The court denied all but one of the motions, deferring for later decision one of the defendants' patent invalidity motions. The court asked VNUS for an additional brief on the deferred invalidity motion because the defendants had raised a new argument in their most recent brief on the issue, and the court sought a response from VNUS before deciding. According to an order issued on Oct. 3, a decision is expected from the court sometime after VNUS submits its additional brief on Oct. 12.

VNUS CEO Brian Farley commented: "Although both sides would have been pleased to have the court grant their respective pre-trial motions, we look forward to putting forth our case in a full trial. We feel strongly that the more the court hears about the success of our technology and the impact it has had on patients' lives, the more compelling our case becomes."

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (Nasdaq:

SOURCE VNUS Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Hospitals Appeal to Citizen Groups to Rush Doctors, Paramedicals
2. Indian Doctor granted US patent on organ regeneration
3. Dr Reddy’s Laboratories to challenge patents on drug
4. Yoga, ayurveda being documented to stop patent misuse
5. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
6. US Court Rules Against Lupin in Ramipril Patent Case
7. HIV Patients Opposes Patenting Of AIDS Drug
8. Provigil Patent Extension Accorded To Cephalon
9. AIDS Sufferers Protest against Proposed Patent for Tenofovir
10. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
11. Venus Remedies Files 5th International Patent Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...tering recipes to cut fat, salt a quick fix withou..., Nov. 22 (HealthDay News) -- You can eat healthie...ng good food choices, say experts with the Texas A... reduce the sugar, fat or salt content of almost a...in taste, nutrition specialist Mary Bielamowicz sa...
(Date:11/21/2008)...nding may lead to new therapies for preterm labor ...Researchers say they,ve found the switch that acti...hildbirth, a finding that may lead to therapies fo...ormally binds the protein IP on the surface of the...nactive during pregnancy. , But researchers fr...
(Date:11/21/2008)...OUSTON(Nov. 21, 2008)The University of Texas Healt...ram, Training Excellence in Aging Studies (TEXAS),...ough a prestigious $2 million award from the Donal...hing funds., "This will allow us to teach geriatr...unior medical student to practicing physicians. Wi...
(Date:11/21/2008)...LINGTON, Va., Nov. 21 T...ased the following statement today from,GPhA Pres...l Trade Commission,(FTC) roundtable on "Emerging ... "The mere fact that the FTC is conducting thi...hind ensuring that consumers have access to safe a...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...nding every waking hour in front of the computer s...in the new year is out of the window and no sooner...While you recline and read this piece, the America...nactive’ trend is disastrous for your heart. ‘Get ...
...h minimal side effects - Scientists of a consortiu... Greece, has been awarded a grant from the Europea...very and validation of new therapeutic strategies ...-named Apotherapy, will develop methods to activat...
... think this piece of news is science fiction; now,...s with the desired characteristics- hair color, ey... advance. The Abraham Center of Life in San Anton...those couples, who are unable to have a biological...
... muscular dystrophy should avoid over exercising, ... or legs after exercise can be caused due to train...essional Association of Neurologists. Muscular dys... that causes progressive muscle weakness and over ...
Other Medicine News:
(Date:11/19/2008)...e/ -- Posit Science Corporation,researcher, Dan T...science,Annual Conference in Washington, DC this ...it Baby Boomers. The computerized brain plasticit...exercises that target auditory and,language syste...ed,improvements in cognition by improving speed a...
(Date:11/19/2008)... statistical significance , , ISELIN, N.J.,...ation (Nasdaq: PARS ) today announced results fr...Emulsion (NE) drug delivery technology formulated ...multi-center, randomized, double-blinded, placebo-... of the Company,s 3% Diclofenac Diethanolamine Nan...
(Date:11/19/2008)...wswire/ -- Biotech scientists increasingly are app... to better understand the effects of novel drug ca...enetic Engineering & Biotechnology News ( GEN... a new compound,s mechanism of action and eventual...ccording to the November 15 issue of GEN . ( http...
(Date:11/19/2008)... Roche- , , MONTVALE, N.J., Nov. 19 /PRNews...asdaq: MEMY ) today announced that it has achiev...487/MEM 3454, its lead alpha-7 nicotinic receptor ...chizophrenia (CIAS). The Company has randomized 2...0 million payment from its partner Roche. Memory ...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Skystar Bio Pharmaceutical Announces Upcoming Interview With WallSt net 28 www wallst net 29 4134 1Skystar Bio Pharmaceutical Announces Upcoming Interview With WallSt net 28 www wallst net 29 4134 2Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 1370 1Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 1370 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 1Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 3Xytis Names Gordon H Busenbark as Chief Financial Officer 576 1Xytis Names Gordon H Busenbark as Chief Financial Officer 576 2
...-AstraZeneca today announced clinical,trial data f...ine,fumarate sustained release), at the European C...monstrated that the SEROQUEL®,sustained releas...se), administered once daily, significantly improv...d by PANSS) and increased the,time to psychiatric ...
...NESS WIRE)--Mar 20, 2007 - Calando,Pharmaceuticals...ity-owned subsidiary of Arrowhead Research Corpora...he Proceedings of the,National Academy of Sciences... first non-human primate study to use multiple, sy...c candidate that is a,nanoparticle containing non-...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 2Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 3Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 5
... ( Percutaneous Transseptal Ventricular Assist) S...odynamic needs of patients for circulatory support...e specialists have historically used intra-aortic ...usion, but the IABP provides minimal circulatory s...
...s of the HeartMate Left Ventricular Assist System ...owered by wearable batteries that allow the patien..., which is powered by an external Drive Console. B...ve heart and are designed to assist the pumping fu...
...lant has been shown to be a highly effective adjun...cible concentrations of fibrinogen and thrombin, T... of the coagulation cascade to produce a biocompat...nective tissue like a natural plasma clot and stop...
The Icy catheter is inserted into the femoral vein and resides in the inferior vena cava. Saline flow within the balloons creates a proprietary vortex flow pattern which maximizes heat exchange with
Medicine Products: